Checkpoint Therapeutics, Inc. (CKPT)
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.
Address
95 SAWYER ROAD
WALTHAM, MA 02453
Founded
2014
Number of Employees
23
Website
http://www.checkpointtx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)